Episode 81- “Bad Shrooms”: Part One: Amatoxin


Episode Summary:

The first of a two-part series discussing poisonous mushrooms. This week, we focus on amatoxin toxicity and presentation.

Show Notes:

Key Points:

“‘Bad Shrooms’: Part One: Amatoxin”:
– Mushrooms that contain amatoxin are a major cause of liver failure around the world. Amatoxin is usually found in the Amanita group of mushrooms (A. phalloides, A. virosa, A.verna, A. ocreata)
– Patients are usually exposed to amatoxin by foraging for mushrooms and mistake toxic mushrooms for edible ones. The estimated lethal dose is 0.1 mg/kg in adults (~ 1-2 medium-sized mushroom caps)
– Amatoxin is absorbed from the intestine and sent to the liver by OATP transporters. Once there, they cause irreparable damage by inhibiting RNA polymerase- stopping cell metabolism and leading to apoptosis
– Amanita toxicity happens in three phases. The first phase typically begins 6-24 hours after ingestion and leads to nausea, watery/bloody diarrhea, and massive fluid losses. In this phase, liver enzymes and bilirubin are typically normal
– The second phase starts ~ 24-36 hours after ingestion. AST and ALT become elevated and peak by 60-72 hours
– The third phase starts ~ 48-96 hours after ingestion. Here, both liver and renal function are severely diminished. Patients can develop hypoglycemia, coagulopathy, hepato-renal syndrome, and hepatic encephalopathy and they can die within 3-7 days without proper support
– Treatment consists mostly of supportive care- and if treatment is started immediately, mortality rates are < 5%.  Some agents, like N-acetyl-cysteine, high-dose penicillin, cyclosporine, and silibinin can be attempted- but a liver transplant may be the only definitive treatment
ER-Rx Episode 81

Please click HERE to leave a review of the podcast!

Transcript:

Hello and welcome to Episode 81 of ER-Rx, a podcast tailored to your clinical needs. I’m your host, Adis Keric, and in this two-part series, I’ll be talking about poisonous mushrooms. This week, I’ll do a quick background about some of these mushrooms, focusing on amatoxin, then next time I’ll talk about treatment options.

Mushrooms that contain amatoxin are pretty rare but they’re a major cause of liver failure and are responsible for 95% of deaths from mushroom ingestions around the world. Amatoxin is usually found in the Amanita group of mushrooms, nicknamed the “deadly white Amanitas” (A. phalloides, A. virosa, A.verna, A. ocreata) with some pretty sick names like “Death Cap,” “Destroying Angel,” and the not-so-sick “Fool’s Mushroom.” But remember that not all Amanita group mushrooms contain the toxin, and that Amanita group mushroom aren’t the only ones that can contain the toxin. For example, other groups of mushrooms, like the Lepiota and Galerina groups can also carry it.

The classic patient is usually exposed to amatoxin by foraging for mushrooms- either to eat or to get high- and mistakes toxic mushrooms for edible ones. But this is still a relatively rare thing. Of the thousands of species of mushrooms, only somewhere between 50-100 are toxic to humans, and only about 35 mushrooms contain amatoxin. The scary thing about amatoxin is that it stays toxic whether you eat it raw or cook it, and to the rookie mushroom-hunter it can be very hard to tell apart dangerous shrooms from safe ones. Another scary thing is that it can be lethal in very small doses. The estimated lethal dose is 0.1 mg/kg or about 7 mg in adults- which is only about 1-2 medium-sized mushroom caps. The good news is that death from amatoxin is pretty rare- with 50 deaths per year in Europe and Asia and only a handful of deaths in the US.

Amatoxins are fascinating compounds. I should also clear up that the term “amatoxin” is an umbrella term for at least 9 related toxic compounds. Anyway, the mechanism by which all of these amatoxins cause damage is pretty complex, but in summary, amatoxins are rapidly absorbed from the intestine and sent to the liver by OATP (organic anion transporting polypeptide) transporters. Once in the liver, they cause irreparable damage by inhibiting RNA polymerase- which if you remember from biochem- hinders transcription of mRNA. Without mRNA, cell metabolism stops and apoptosis starts.

The liver is hit the hardest because it’s the first organ that amatoxin sees after absorption from the GI tract. But other organs that also have rapid cellular turnover, likes cells of the GI tract or the kidneys, are also affected.

Amanita toxicity happens in three phases. The first phase typically begins 6-24 hours after ingestion. Patients can feel nauseous and crampy and will have large amounts of watery and even bloody diarrhea. Massive fluid losses can lead to hypovolemia, acute kidney injury, and shock. In this phase, liver enzymes and bilirubin are typically normal.

The second phase, which starts around 24-36 hours after ingestion, is characterized by patients typically starting to feel a little better from a GI standpoint. During this phase, AST and ALT become elevated and peak 60-72 hours post-ingestion. In very severe poisonings, this phase can be skipped altogether and patients can go directly from phase one to phase three.

In the third phase, which happens about 48-96 hours after ingestion, both liver and renal function are severely diminished. Loss of liver function means patients can develop hypoglycemia, coagulopathy, hepato-renal syndrome, and hepatic encephalopathy and they can die within 3-7 days without proper support.

Diagnosis is mostly based on the history of delayed-onset GI symptoms or hepatoxicity after eating a mushroom. You can also try to identify the mushroom, but we shouldn’t wait for identification before providing treatment- and identification should only be attempted by an expert medical toxicologist—so obviously involved your tox team or poison control center immediately.

Treatment consists mostly of supportive care- and if treatment is started immediately, we can keep the mortality rate of these poisonings to < 5%. Some agents, like N-acetyl-cysteine, high-dose penicillin, cyclosporine, and silibinin can be attempted- but if it gets bad enough a liver transplant may be the only definitive treatment.

Next week, we’ll go over some of these treatments more in depth- with a useful guide on how to get silibinin- from personal experience.

As always, thank you so much for your time, and thank you for wanting to learn more about pharmacotherapy. If you have any comments or anything you’d like to add to this episode, please give me a shout out on the @errxpodcast Instagram page, or reach out to me on errxpodcast.com- I’d love to respond to all comments and criticisms.

I also want to take a second to shout out listener Li Sha for her very generous donation on BuyMeACoffee.com- donations like this keep the podcast running and free for everyone. I’ll see you next time.

References:


2 Replies to “Episode 81- “Bad Shrooms”: Part One: Amatoxin”

  1. E.R.H

    First time listener… Great podcast but I was wondering does this type of poisoning happen that often with mushrooms that are taken for “recreational ” purposes?

    • errxpodcast

      I would imagine that this type of poisoning can happen for any purpose. If the person collecting the mushroom misidentifies it as a “recreational” mushroom, then that’s a problem.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Reviews/ Comments

“Love this podcast for anyone working in an ER or ICU. If you aren’t a pharmacist you will still get tons of useful information to improve your practice. Adis has a knack for finding a happy balance between explaining the pharmacokinetics and practical use for patients at the bedside. Highly recommend!”

–  NotAPharmacist, Apple Podcasts review 

“Perfect amount of knowledge in a great length to refresh ICU and ED topics. Explains concepts in an easy to understand fashion”

–  RxLaura, Apple Podcasts review

“I love listening to this podcast because I can listen to 1 or 2 on my way to work and it provides great info! As a paramedic, this podcast has really helped me understand the “why” we give certain meds.”

cresjr, Apple Podcasts review

“Ideal podcast to listen on the way to my shift. Learning points throughout!”

andmatjos, Apple Podcasts review

“I’m currently in my last year of pharmacy school […] I just happen to come across your podcast on YouTube as I was trying to find a good explanation regarding the misleading sulfa allergy in non-antibiotic sulfonamides. Your explanation was great. I can’t believe I’m only now finding out about your podcasts but please continue to make them for as long as you can. Prospective pharmacists, such as myself, really appreciate you taking the time to put such great educational content out there.”

– S.P., Pharmacy Student

“Adis does a wonderful job of gathering the evidence-based answers to the hard questions that we all get as pharmacists and putting them into a nice, neat package.”

– rebroush1, Apple Podcasts review

“This is a great podcast to listen to at work and is not too overwhelming and well put together. Highly recommended for anyone in healthcare, even outside of emergency medicine.”

Peelage, Apple Podcasts review

“Great reviews on drug-related topics with useful details on drug mechanisms, pharmacodynamics and administration considerations as well as data to support recommendations. Great for pharmacists, providers and learners!”

-JaayyZzee, Apple Podcasts review

“I found the topics very helpful. I have been recommending this show to pharmacy students and residents, who are also enjoying it.”

hvgjnfd, Apple Podcasts review

“As a PA, I found this very informative. I like that the episodes are short, making them easy to listen to on my way to and from work. Would love to hear more pediatric topics!”

-Pediatric PA, Apple Podcasts review

“Good podcast thats very informative for all healthcare providers. Very easy to listen to and enjoy.”

-Bradlley88, Apple Podcasts review